About Carlo Traverso
Form D filings for Lyndra Therapeutics from 2016 to 2023 list Carlo Traverso as director.
Carlo Traverso first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Carlo Traverso in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Carlo Traverso works with at each company, as listed on that company's latest Form D.
Lyndra Therapeutics, Inc. · Form D, Dec 29, 2023
ZA
Zafi Avnur
Director
AS
Ashish Singh
Director
JB
Jessica Ballinger
Chief Executive Officer and director
RL
Robert Langer
Director
DD
Doug Dachille
Director
AS
Amy Schulman
Director
PH
Patricia Hurter
Director
CR
Catherine Reynolds
Director
HM
Helene Madonick
Director